Omega-3 Fatty Acids in Elderly Patients With Acute Myocardial Infarction

Giving Omega-3 Fatty Acids to Elderly Patients Diagnosed With Acute Myocardial Infarction to Investigate the Effect on Cardiovascular Morbidity and Mortality

The aim of the present study is to investigate the possible effects of supplementation with 1.8 g/day of n-3 polyunsaturated fatty acids on cardiovascular morbidity and mortality during a follow-up period of 2 years in an elderly population after having experienced an acute myocardial infarction.

The hypothesis is that this supplementation on top of modern therapy will reduce the combined cardiovascular end-point of death, non-fatal myocardial infarction, stroke, revascularizations or hospitalization for new or worsened heart failure with at least 30%.

Inclusion Criteria:

• Patients with acute myocardial infarction discharged from hospital alive

Exclusion Criteria:

• Being part of another randomized trial
• Documented intolerance for omega-3 fatty acids
• Additional disease state that is thought to be incompatible with compliance to the study drugs
• Additional disease state thought to reduce survival for the follow-up time of 2 years